Course of the Diverticular Disease: What is changing?


Journal

Journal of gastrointestinal and liver diseases : JGLD
ISSN: 1842-1121
Titre abrégé: J Gastrointestin Liver Dis
Pays: Romania
ID NLM: 101272825

Informations de publication

Date de publication:
19 Dec 2019
Historique:
received: 30 10 2019
accepted: 14 12 2019
entrez: 14 1 2020
pubmed: 14 1 2020
medline: 23 6 2020
Statut: epublish

Résumé

In this session several critical issues in diverticular disease were considered, including "It is Symptomatic Diverticular Disease or Irritable Bowel Syndrome?", "What do determine evolution to diverticulitis, bowel habits alteration or inflammation?", and "Prevention of acute diverticulitis: Is it at all possible?". The first talking compared symptoms and laboratory findings between Symptomatic Uncomplicated Diverticular Disease  (SUDD) and Irritable Bowel Syndrome (IBS). Although both disease share some symptoms, and although IBS can occur in patients having diverticulosis,  SUDD and IBS can be differentiate using a combination of symptoms and laboratory tools. The second talking debated what are the most important risk factors for the evolution towards acute diverticulitis. Current data seem to exclude a significant role of bowel habits alteration, while inflammation seems to have a stronger role, especially in causing acute diverticulitis recurrence. The third talking analyzed about the acute diverticulitis prevention. Primary prevention seem to be little better when using mesalazine, while no definite conclusion can be drawn about the use of fiber and rifaximin. About the secondary prevention, no drugs can be currently advised due to lacking of definite results. At the same time, surgery should be advised on case-by-case basis.

Identifiants

pubmed: 31930229
doi: 10.15403/jgld-552
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11-16

Auteurs

Tomica Milosavljeviĉ (T)

Clinical Centre of Serbia, University of Belgrade, Serbia. . tommilos@hotmail.com.

Giovanni Brandimarte (G)

Division of Internal Medicine and Gastroenterology, "Cristo Re" Hospital, Rome, Italy. giovannibrandimarte56@gmail.com.

Neil Stollman (N)

Division of Gastroenterology, Alta Bates Summit Medical Center, East Bay Center for Digestive Health, 300 Frank H Ogawa Plaza, Oakland, CA, USA. neil@stollman.com.

Giovanni Barbara (G)

Department of Clinical Medicine, Section of Gastroenterology, "S. Orsola" Hospital, University of Bologna, Bologna, Italy. giovanni.barbara@unibo.it.

Adi Lahat (A)

Department of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 52651, Israel. zokadi@gmail.com.

Carmelo Scarpignato (C)

Faculty of Medical Sciences, United Campus of Malta, San Ġiljan, Malta. scarpi@tin.it.

Angel Lanas (A)

Digestive Diseases Service. University Clinic Hospital. Aragón Health Research Institute (IIS Aragón), University of Zaragoza School of Medicine. CIBERehd. Zaragoza. Spain. angel.lanas@gmail.com.

Valerio Papa (V)

Division of General Surgery, "S. Carlo di Nancy" Hospital, Rome, Italy. valerio.papa@msn.com.

Antonio Tursi (A)

Territorial Gastroenterology Service, ASL BAT, Andria, Italy. antotursi@tiscali.it.

Gerardo Nardone (G)

Department of Clinical and Experimental Medicine, University "Federico II", Naples, Italy. nardone@unina.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH